Related references
Note: Only part of the references are listed.A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III
Xing He et al.
JOURNAL OF HEPATOLOGY (2020)
Necroptosis and Caspase-2-Mediated Apoptosis of Astrocytes and Neurons, but Not Microglia, of Rat Hippocampus and Parenchyma Caused by Angiostrongylus cantonensis Infection
Hongli Zhou et al.
FRONTIERS IN MICROBIOLOGY (2020)
Relationships among host microbiota, parasite resistance or tolerance, and host fitness
Andreas Eleftheriou
CONSERVATION BIOLOGY (2020)
Schistosoma mansoni Worm Infection Regulates the Intestinal Microbiota and Susceptibility to Colitis
Achilleas Floudas et al.
INFECTION AND IMMUNITY (2019)
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
Israr Khan et al.
PATHOGENS (2019)
2-O-β-D-Glucopyranosyl-L-ascorbic Acid, an Ascorbic Acid Derivative Isolated from the Fruits of Lycium Barbarum L., Modulates Gut Microbiota and Palliates Colitis in Dextran Sodium Sulfate-Induced Colitis in Mice
Kaiyin Huang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice
Graham J. Britton et al.
IMMUNITY (2019)
Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota
Minna Wu et al.
PHARMACOLOGICAL RESEARCH (2019)
Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis
Sandeep A. Walujkar et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2018)
Dectin-1/2-induced autocrine PGE(2) signaling licenses dendritic cells to prime Th2 responses
Maria M. M. Kaiser et al.
PLOS BIOLOGY (2018)
Host Defense Versus Immunosuppression: Unisexual Infection With Male or Female Schistosoma mansoni Differentially Impacts the Immune Response Against Invading Cercariae
Martina Sombetzki et al.
FRONTIERS IN IMMUNOLOGY (2018)
Modulation of Host Immunity by Helminths: The Expanding Repertoire of Parasite Effector Molecules
Rick M. Maizels et al.
IMMUNITY (2018)
Early Induction of Human Regulatory Dermal Antigen Presenting Cells by Skin-Penetrating Schistosoma Mansoni Cercariae
Beatrice M. F. Winkel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Gut microbiota and IBD: causation or correlation?
Josephine Ni et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance
Meng Wang et al.
PARASITOLOGY RESEARCH (2017)
Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes
Yangyang R. Yu et al.
SEMINARS IN PEDIATRIC SURGERY (2017)
Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance
Sean M. McNabney et al.
NUTRIENTS (2017)
rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway
Lifu Wang et al.
THERANOSTICS (2017)
Innate Lymphoid Cells in Intestinal Inflammation
Alessandra Geremia et al.
FRONTIERS IN IMMUNOLOGY (2017)
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease
Alexa R. Weingarden et al.
GUT MICROBES (2017)
Inflammatory Bowel Diseases (IBD) immunopathogenesis: A comprehensive review of inflammatory molecules
Jae Hyon Park et al.
AUTOIMMUNITY REVIEWS (2017)
Parasites promote protective microbiota
Iain Dickson
Nature Reviews Gastroenterology & Hepatology (2016)
Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease
Francesca Pistollato et al.
NUTRITION REVIEWS (2016)
Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut
Michael R. Howitt et al.
SCIENCE (2016)
The gut microbiota and inflammatory bowel disease
Yoshiyuki Goto et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
The global burden of IBD: from 2015 to 2025
Gilaad G. Kaplan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
The hygiene hypothesis: current perspectives and future therapies
Leah T. Stiemsma et al.
IMMUNOTARGETS AND THERAPY (2015)
Inflammatory bowel disease: Pathogenesis
Yi-Zhen Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analyses
Monia Marchetti et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2014)
The gut microbiota in mouse models of inflammatory bowel disease
Kalliopi K. Gkouskou et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity
Dana Ben-Ami Shor et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Induced and Natural Regulatory T Cells in the Development of Inflammatory Bowel Disease
Christopher G. Mayne et al.
INFLAMMATORY BOWEL DISEASES (2013)
The burden of inflammatory bowel disease in Europe
Johan Burisch et al.
JOURNAL OF CROHNS & COLITIS (2013)
Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice
Holger Sann et al.
LIFE SCIENCES (2013)
IL-1 beta Suppresses Innate IL-25 and IL-33 Production and Maintains Helminth Chronicity
Mario M. Zaiss et al.
PLOS PATHOGENS (2013)
Immunotherapy with IL-10-and IFN-γ-producing CD4 effector cells modulate Natural and Inducible CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer
Mark J. Dobrzanski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
New pathogenic paradigms in inflammatory bowel disease
Antonio Di Sabatino et al.
INFLAMMATORY BOWEL DISEASES (2012)
Review article: loss of response to anti-TNF treatments in Crohn's disease
S. Ben-Horin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Current and emerging drugs for the treatment of inflammatory bowel disease
John K. Triantafillidis et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2011)
Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells
Marc P. Hubner et al.
IMMUNOLOGY (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Molecular analysis of the gut microbiota of identical twins with Crohn's disease
Johan Dicksved et al.
ISME JOURNAL (2008)
Schistosoma japonicum eggs modulate the activity of CD4+ CD25+ Tregs and prevent development of colitis in mice
Hong-mei Mo et al.
EXPERIMENTAL PARASITOLOGY (2007)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Trichuris suis therapy for active ulcerative colitis:: A randomized controlled trial
RW Summers et al.
GASTROENTEROLOGY (2005)
Share Paper
